Alirocumab’s ODYSSEY continues: Efficacy unaffected by insulin, beats fenofibrate. #EASD2017 http://bit.ly/2whGXdr pic.twitter.com/SjDkNRHFhY
1:15 PM - 15 Sep 2017
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.